• Home
Scientific article
OA Policy
English

A living WHO guideline on drugs for covid-19

ContributorsLamontagne, François; Agoritsas, Thomasorcid; Macdonald, Helen; Leo, Yee-Sin; Diaz, Janet; Agarwal, Arnav; Appiah, John Adabie; Arabi, Yaseen; Blumberg, Lucille; Calfee, Carolyn S; Cao, Bin; Cecconi, Maurizio; Cooke, Graham; Dunning, Jake; Geduld, Heike; Gee, Patrick; Manai, Hela; Hui, David S; Kanda, Seema; Kawano-Dourado, Leticia; Kim, Yae-Jean; Kissoon, Niranjan; Kwizera, Arthur; Laake, Jon Henrik; Machado, Flavia R; Qadir, Nida; Sarin, Rohit; Shen, Yinzhong; Zeng, Linan; Brignardello-Petersen, Romina; Lytvyn, Lyubov; Siemieniuk, Reed; Zeraatkar, Dena; Bartoszko, Jessica; Ge, Long; Maguire, Brittany; Rochwerg, Bram; Guyatt, Gordon; Vandvik, Per Olav
Published inBMJ (Clinical Research Edition), vol. 370, m3379
Publication date2020
Abstract

What is the role of drug interventions in the treatment and prevention of covid-19?

Keywords
  • Adrenal Cortex Hormones/therapeutic use
  • Betacoronavirus
  • Coronavirus Infections/drug therapy
  • Humans
  • Pandemics
  • Pneumonia
  • Viral/drug therapy
  • World Health Organization
Affiliation entities
Research groups
Citation (ISO format)
LAMONTAGNE, François et al. A living WHO guideline on drugs for covid-19. In: BMJ (Clinical Research Edition), 2020, vol. 370, p. m3379. doi: 10.1136/bmj.m3379
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Commercial URLhttps://www.bmj.com/content/370/bmj.m3379
Journal ISSN0959-8138
315views
1631downloads

Technical informations

Creation19/09/2020 16:59:00
First validation19/09/2020 16:59:00
Update time15/03/2023 22:41:02
Status update15/03/2023 22:41:00
Last indexation31/10/2024 19:49:41
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack